CLICK HERE FOR CERTIFICATE OF ANALYSIS
ALL INFORMATION LISTED BELOW IS INTENDED SOLELY FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY. THIS IS A RESEARCH PRODUCT AND IS INTENDED FOR RESEARCH USE ONLY. THESE COMPOUNDS ARE NOT APPROVED FOR HUMAN CONSUMPTION. DO NOT CONSUME THEM.
Ostarine or MK2866 has been a "Research Favorite" for years as it is noted to be very powerful for fat loss and lean muscle growth while exhibiting extremely low toxicity or any side effects. Ostarine is one of the most popular and most widely studied among selective androgen receptor modulators (SARMs), Ostarine —also called MK-2866, GTX 024, or Enobosarm —arrived on the scene back in the late 1990s as an experimental treatment for osteoporosis and certain diseases that cause insulin resistance, muscle wasting, and muscle loss.
Ostarine is the closest SARM to being approved for medical treatment and is currently in phase II clinical trials. Like SARMs in general, MK-2866 targets androgen receptors on a selective basis and avoids generating the kinds of harmful side effects associated with substances like testosterone, human growth hormone, or anabolic steroids like water retention or virilization.
Ostarine is considered by many researchers to be the best SARM for cutting bodyfat and building lean muscle. It has been observed as generally safe and well tolerated at doses up to 18mg per day for 12 months in female cancer patients. Unlike testosterone and most other androgen receptor mediated anabolic agents, it is orally bioavailable so it does not require injection for proper absorption. Ostarine also seems to be one of the most favorable sarms for females.
Muscle Growth *****
Fat Loss *****
Endurance and Power ****
Body Recomposition *****
MK-2866 has demonstrated a variety of potential benefits in research, such as:
- Increases muscle mass, growth and strength
- Joint healing capabilities
- Helps maintain Muscle Mass when calorie deficit
- Improves and protects Heart Health
- Builds endurance
- Accelerates healing
- Clears the skin
- Increased Insulin resistance
- Helps with Bone health
- Does not convert to DHT or Estrogen
- A key component that is ideal for weight loss
CYCLE LENGTH – 12 WEEKS IS BEST FOR OPTIMAL RESULTS.
DOSAGE – 1 Capsule 3 x per day (Every 4-5 hours)
HALF LIFE 24 HOURS
------------------------------------------------------------------------------------In Spanish for Our Latin Friends
En Espanol
- Aumenta la masa muscular, el crecimiento y la fuerza.
- Capacidades de curación articular
- Ayuda a mantener la masa muscular cuando hay déficit de calorías.
- Mejora y protege la salud del corazón
- Desarrolla la resistencia
- Acelera la curación
- Aclara la piel
- Mayor resistencia a la insulina
- Ayuda con la salud ósea
- No se convierte en DHT o estrógeno
- Un componente clave que es ideal para adelgazar
DURACIÓN DEL CICLO: 12 SEMANAS ES LO MEJOR PARA OBTENER RESULTADOS OPTIMOS.
DOSIS – 1 capsule 3x por dia
MEDIA VIDA 24 HORAS
--------------------------------------------------------------------------------------------
DISCLAIMER
By purchasing from SRLABZ you agree that you are purchasing Research Chemicals.
SRLABZ SARMS products are furnished for LABORATORY RESEARCH USE ONLY.
This product should only be handled by qualified and licensed professionals. The product may not be used as a drug, agricultural or pesticide product, food additive, or household chemical – and may not be misbranded as such. All information on this website is available for educational purposes only. Bodily introduction of any kind into humans and/or animals is strictly forbidden by law.
*SARMS ARE NOT DIETARY SUPPLEMENTS.
*Research chemicals are chemical substances used by scientists for medical and scientific research purposes. One characteristic of a research chemical is that it is for laboratory research use only; a research chemical is not intended for human or veterinary use. This distinction is required on the labels of research chemicals and is what exempts them from regulation under parts 100-740 in Title 21 of the Code of Federal Regulations (21CFR).
